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INTRODUCTION
Death rates from coronary heart disease (CHD) have dec-
lined substantially in the United States and Western coun-
tries in recent decades (1). In contrast, the Asia-Pacific region
accounts for about half of the global burden of cardiovascu-
lar disease (CVD) (2). Moreover, recent mortality from ische-
mic heart disease has increased 2.4-fold since 1990 in Korea
(3). The decline of mortality from CHD in Western countries
is attributable to changes in risk factors and medical thera-
pies based on a variety of evidence (1). Conversely, the increase
in the death rate from CHD in Asia may be due to a gradu-
al increased exposure to Westernized lifestyles.
Several clinical trials have reported no association between
homocysteine-lowering therapy and reduction of CVD events
(4, 5). However, these trials lacked sufficient statistical power
to confirm the association between serum homocysteine lev-
els and CVD (6). Hyperhomocysteinemia is widely recognized
as a major independent risk factor for CVD, comparable to
the effect of smoking or hyperlipidemia (7). Moreover, hyper-
homocysteinemia is an easily modifiable risk factor for CVD
(8). Therefore, a study identifying factors that effectively lower
the serum homocysteine levels in an Asian sample with an
increased risk for CHD is warranted. In particular, the fac-
tors that determine serum homocysteine levels, including
lifestyle factors, need to be ascertained.
The results of previous work have suggested that serum
concentrations of homocysteine may be influenced by the
following factors: demographic factors (increased age, male
sex, and ethnic origin); genetic variations (the methylenete-
trahydrofolate reductase and cystathionine b-synthase gene);
physiological and clinical factors (reduced renal function, in-
creasing muscle mass, and deficiencies in folate, vitamin B12,
and vitamin B6); disease states (diabetes mellitus, hypothy-
roidism, nephropathy or end-stage renal disease, and obesi-
ty); hormonal factors (menopause, thyroid deficiency, and
some oral contraceptive use); lifestyle factors (smoking, exces-
sive alcohol consumption, low intake of folate and B-vitamins,
excessive coffee consumption, and lack of physical activity);
and several drugs (including folate-, vitamin B12- and vita-
min B6-antagonists) (8, 9). 
Several studies have attempted to determine the factors
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Major Determinants of Serum Homocysteine Concentrations in 
a Korean Population
The objective of this study was to identify the factors that determine serum homo-
cysteine concentrations in Korean population. In a community-based study, 871
participants completed detailed questionnaires and physical examination. We found
that increased age, male sex, family history of stroke, deficiencies of serum folate
and vitamin B12, and elevated serum creatinine significantly increased the risk of
hyperhomocysteinemia. However, hormonal and behavioral factors (smoking, alco-
hol drinking, coffee consumption, and sedentary time) were not associated with
the risk of hyperhomocysteinemia. The risk of hyperhomocysteinemia was steeply
increased in subjects with two or more risk factors among four selected risk factors
(deficiencies of serum folate and vitamin B12, elevated creatinine, and family his-
tory of stroke) compared to subjects who did not have any risk factors, especially
subjects over the age of 65 yr (odds ratio [OR], 33.5; 95% confidence interval [CI],
3.71-302.0 in men; OR, 39.2; 95% CI, 7.95-193.2 in women). In conclusion, increas-
ed age, male sex, family history of stroke, deficiencies of serum folate and vitamin
B12, and elevated serum creatinine are important determinants of serum homocys-
teine concentrations with interaction effects between these factors.
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have been based on medical patients or pregnant women. A
few population-based studies have been conducted, but had
small population samples (10, 11) or were restricted to asso-
ciations with physiological factors, such as serum folate and
vitamin B12 concentrations (12). To date, no comprehensive
studies on the various factors that determine the serum con-
centrations of homocysteine have been carried out in Korea.
Therefore, we assessed the acquired (i.e., physiological and
clinical factors, disease state, and hormonal factors) and behav-
ioral determinants of homocysteine concentration and inter-
action effects between these factors through a comprehensive
survey of a community-based Korean population.
MATERIALS AND METHODS
Subjects
This study, which is part of a population-based cohort study
on CVD, was conducted in a rural area (Yangpyeong Coun-
ty) of Korea. All adults who were greater than 20 yr old in
the targeted villages were invited to the Health Examination
Service in cooperation with the Yangpyeong Public Health
Center. Among a total of 907 adults who participated in this
comprehensive examination survey from February 2001 to
February 2002, serum samples from 889 subjects were avail-
able for the analysis of serum total homocysteine (tHcy), folate,
and vitamin B12. A total of 18 participants were excluded
from the final analysis due to the absence of clinical data (three
people) and incomplete questionnaires (15 people). There-
fore, 871 subjects were included in the current study. The
mean age of 364 men was 55.8±13.3 yr (range 19-88) and
of 507 women was 54.9±13.5 yr (range 19-87). The study
protocol was approved by the Institutional Review Board of
Hanyang University Hospital (2002-2).
Data collection
All screenings and interviews were performed by trained
staff in the Yangpyeong Community Health Center of Han-
yang University. A detailed description of this study’s method-
ology has been published in our previous study aimed at estab-
lishing a reference value for serum tHcy using the same sam-
ple (13).
Questionnaire
Face-to-face interviews were conducted by trained inter-
viewers. The questionnaire was composed of demographics
(age, sex, marital status, occupation, education, and income),
family history, medical history, reproductive history (meno-
pause, oral contraceptive use), lifetime tobacco usage, alco-
hol consumption, physical activity, and coffee consumption
(consumption frequency per month, week, or day). 
Physical examinations
After changing into supplied clothing, each participant’s
height and weight were measured according to the study pro-
tocol. Body mass index (BMI) was calculated as the ratio of
weight to height squared (kg/m2).
Blood sample collection and biochemical analysis
Venous blood samples were obtained after at least an eight-
hour fast. Within two hours after blood collection, one 10-
mL plain tube was centrifuged at 2,500-3,000 rpm for 10
min and the serum fraction was separated into several aliquots.
The serum was put in ice and transported to the laboratory.
Serum creatinine was assayed using a Hitachi 747 analyzer
(Hitachi High-Technologies Corporation, Tokyo, Japan) on
the same day it was drawn. The remnant blood samples were
then stored at -70℃, and then the serum concentrations of
tHcy, folate, and vitamin B12 were determined using a micro-
particle immunoassay (MPIA) on an Axsym machine (Abbott
Diagnostics, Abbott Park, IL, USA).
Statistical analyses 
In our previous study (13) aimed at establishing a reference
value for serum tHcy, we used 506 out of 889 subjects as a
reference population. These subjects had adequate serum lev-
els of folate (≥11.3 nM/L), vitamin B12 (≥185 pM/L), and
creatinine (≤110 mM/L for men and ≤90 mM/L for women),
after excluding individuals with a medical history of angina
or myocardial infarction from the study sample. The sex-spe-
cific 2.5th and 97.5th percentile values for the tHcy concen-
tration in the reference population were then determined as
reference intervals according to the guidelines of the Clinical
and Laboratory Standards Institute (14). Levels that exceed-
ed the sex-specific 97.5th percentile values (15.31 mM/L for
men, 12.69 mM/L for women) were defined as hyperhomo-
cysteinemia. Serum folate was classified as deficient (<6.8
nM/L), borderline (6.8-11.2 nM/L), or normal (≥11.3 nM/L)
(15). Serum vitamin B12 was classified as deficient (<148
pM/L), borderline (148-184.9 pM/L), or normal (≥185 pM/
L) (16). Elevated levels of serum creatinine were defined as
>110 mM/L for men and >90 mM/L for women (17). The sub-
jects were divided into three categories on the basis of BMI:
≤normal weight (<23 kg/m2), overweight (23-24.9 kg/m2),
or obese (≥25 kg/m2) according to the re-defined WHO
criterion for obesity in the Asia Pacific region (18). 
To improve the normality of the skewed serum tHcy, folate,
vitamin B12, and creatinine concentration distributions, these
values were logarithmically transformed and are presented as
geometric means with 95% confidence intervals. Significant
differences between men and women were compared using
a t-test for continuous variables and a chi-square-test for cate-
gorical variables. Significant mean differences in serum tHcy,
folate, and vitamin B12 concentrations among the four age
groups (<45, 45-54, 55-64, ≥65 yr) were compared using
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ear regression. P values less than 0.05 were considered statis-
tically significant. Multivariate logistic regression was used
to calculate the odds ratios (OR) and the corresponding 95%
confidence intervals (CI) adjusted for the factors associated
with hyperhomocysteinemia. Previous studies have reported
that smokers (19) and alcoholics (20) have lower blood and
tissue concentrations of folate and vitamin B12. These find-
ings suggest the possibility that the effects of smoking and
alcohol consumption on tHcy levels may be mediated in part
through folate. For this reason, we excluded folate and vita-
min B12 in the statistical model for examining the effect of
smoking and drinking. Analyses were conducted using SPSS
12.0 (SPSS Inc., Chicago, IL, USA). 
RESULTS
The distributions of the general characteristics and vari-
ables that were expected to contribute to serum homocys-
teine concentration are shown in Table 1. The mean tHcy
concentration was higher in men compared to women (11.2
mM/L for men, 8.4 mM/L for women, P<0.001). Also, the
prevalence of hyperhomocysteinemia among men (13.5%)
was significantly higher than that of women (7.9%). The
rates of higher education and current smoking and alcohol
drinking as well as the mean concentration of serum creati-
nine were significantly higher in men compared to women,
while the prevalence of obesity (>25 kg/m2) and the mean
concentrations of serum folate and vitamin B12 were signif-
icantly higher in women compared to men. Only 14% of the
men and 2.8% of the women were classified as folate defi-
cient on the basis of a 6.8 nM/L cutoff point.
Table 2 shows the means and 95% CI for the serum con-
centrations of tHcy, folate, and vitamin B12 according to four
age groups (<45, 45-54, 55-64, ≥65 yr). The mean tHcy
concentration increased significantly with age in both men
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*arithmetic mean±SD; 
� geometric mean (95% confidence interval); 
� Only
first-degree relatives were included, 
�
sum of the time spent sedentary
while eating at a table, watching TV, driving the car and taking the bus,
sitting indoors (reading a book, knitting, or talking, etc.), and working in
a seated position; 
‖cut-off points of hyperhomocysteinemia >15.31 mM/L
for men and >12.69 mM/L for women; 
¶>110 mM/L for men and >90 mM/L
for women; P values for differences between men and women were cal-
culated by a t-test for continuous variables and by a c2-test for categor-
ical variables.
Variables
Men 
(n=364)
Women
(n=507)
P
value
Age (yr)* 55.8±13.3 54.9±13.5 0.335
Higher education (≥12 yr, %) 32.5 19.1 <0.001
Family history of stroke (Yes, %)
� 15.1 17.2 0.419
Diabetes mellitus (Yes, %) 10.2 10.5 0.890
Obesity (>25 kg/m
2, %) 36.5 52.1 <0.001
Menopause (Yes, %) - 64.3 -
Oral contraceptive use (Yes, %) - 19.9 -
Current smoker (Yes, %) 52.7 7.5 <0.001
Current drinker (Yes, %) 70.1 32.9 <0.001
Coffee consumption  30.6 29.1 0.476
(≥2 cups/day, %)
Sedentary time (hr/day)*,� 7.7±3.8 7.8±4.4 0.689
Serum homocysteine (mM/L)
� 11.2 8.4  <0.001
(10.8-11.7) (8.1-8.7)
Hyperhomocysteinemia (%)
‖ 13.5 7.9 0.007
Serum folate (nM/L)
� 11.8 16.0  <0.001
(11.3-12.4) (15.5-16.5)
Deficient (<6.8 nM/L, %) 14.0 2.8 <0.001
Serum vitamin B12 (pM/L)
� 258 296  <0.001
(246-270) (283-309)
Deficient (<148 pM/L, %) 11.3 8.5 0.212
Serum creatinine (mM/L)
� 85.8 68.5  <0.001
(84.4-87.2) (67.7-69.4)
Elevated (%)
¶ 3.3 2.0 0.219
Table 1. Distribution of the general characteristics and serum
concentration of homocysteine, folate, vitamin B12, and creati-
nine in the study subjects
Different letters indicates significant differences according to ANOVA (P<0.05); *geometric mean (95% confidence interval); 
� P for trends were calculat-
ed by linear regression.
Age (yr) Homocysteine (mM/L) No. Folate (nM/L) Vitamin B12 (pM/L)
Men (n=364) Mean (95% Confidence Interval)*
<45 83 10.3 (9.6-11.1)
a 11.0 (10.0-12.1) 235.9 (215.4-258.3)
a
45-54 76 11.0 (10.0-12.2)
a,b 11.7 (10.7-12.9) 286.3 (260.6-314.5)
b
55-64 94 11.2 (10.5-11.9)
a,b 12.5 (11.5-13.6) 277.0 (250.3-306.6)
a,b
≥65 111 12.3 (11.5-13.2)
b 12.0 (10.9-13.2) 242.2 (221.4-265.0)
a,b
P for trend
� <0.001 0.125 0.892
Women (n=507) Mean (95% Confidence Interval)*
<45 135 7.3 (7.0-7.7)
a 16.3 (15.4-17.3) 305.9 (282.4-331.3)
a,b
45-54 83 7.6 (7.2-7.9)
a 15.7 (14.4-17.1) 293.8 (264.4-326.4)
a,b
55-64 142 8.6 (8.2-9.0)
b 16.4 (15.5-17.4) 316.1 (291.3-343.1)
a
≥65 147 9.9 (9.2-10.6)
c 15.5 (14.4-16.6) 271.4 (248.9-295.8)
b
P for trend
� 0.001 0.391 0.134
Table 2. Serum concentrations of homocysteine, folate, and vitamin B12 by sex and age(Pfor trend <0.001; 10.3 mM/L for men <45 yr vs. 12.3 mM/
L for men ≥65 yr) and women (Pfor trend= 0.001; 7.3 mM/
L for women <45 yr vs. 9.9 mM/L for women ≥65 yr). How-
ever, the serum concentrations of folate and vitamin B12 were
not associated with increased age.
The associations between hyperhomocysteinemia and serum
folate, vitamin B12, or creatinine levels are described in Table
3. Both folate deficiency (OR, 10.8; 95% CI, 4.35-26.9 in
men; OR, 4.55; 95% CI, 1.01-20.6 in women) and vitamin
B12 deficiency (OR, 2.67; 95% CI, 1.09-6.50 in men; OR,
6.00; 95% CI, 2.48-14.6 in women) were significantly asso-
ciated with hyperhomocysteinemia. The prevalence of hyper-
homocysteinemia was highly increased with the degree of
folate deficiency (6.2% for men and 4.7% for women in the
normal group vs. 35.3% for men and 28.6% for women in
the deficient group) and vitamin B12 deficiency (11.6% for
men and 6.0% for women in the normal group vs. 26.8%
for men and 30.2% for women in the deficient group). Ele-
vated serum creatinine was also highly associated with the
risk of hyperhomocysteinemia (OR, 19.7; 95% CI, 4.79-81.2
in men; OR, 19.6; 95% CI, 3.96-96.7 in women). 
As shown in Table 4, the risk of hyperhomocysteinemia
was significantly increased when both serum folate and vita-
min B12 were deficient (OR, 31.7; 95% CI, 7.20-139.8).
In addition, the interaction between folate and vitamin B12
concentrations was significant (P<0.001).
Table 5 shows the associations between hyperhomocys-
teinemia and family history, disease status, or hormonal and
lifestyle factors. Only a family history of stroke was signifi-
cantly associated with the risk of hyperhomocysteinemia in
women (OR, 3.49; 95% CI, 1.34-9.06). Diabetes mellitus,
BMI, hormonal factors (menopause and oral contraceptive
use), and behavioral factors (smoking, alcohol drinking, cof-
fee consumption, and sedentary time) were not associated
with the risk of hyperhomocysteinemia.
Table 6 shows the risks of hyperhomocysteinemia accord-
ing to the total number of the four selected risk factors (serum
folate and vitamin B12 deficiency, elevated creatinine, and
family history of stroke) in each sex and age group. In con-
trast to subjects without any risk factors, the risk of hyper-
homocysteinemia was steeply increased in subjects with two
or more risk factors. This was especially true in both men and
women over the age of 65 (OR, 33.5; 95% CI, 3.71-302.0
in men; OR, 39.2; 95% CI, 7.95-193.2 in women).
DISCUSSION
The mean serum concentrations of tHcy in our study pop-
ulation (11.2 mM/L in men, 8.4 mM/L in women) were lower
than those of healthy adults in Japan (21) and north China
(12). However, the mean concentrations from our study pop-
ulation were higher than those of healthy adults in the US
(22) and were similar to the Singapore Chinese (23) and a rural
population of Costa Rica (24). In addition, the serum con-
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OR, odds ratio adjusted for age and serum concentrations of folate, vitamin B12, and creatinine; *cut-off points of hyperhomocysteinemia were >15.31
mM/L for men and >12.69 mM/L for women; 
� >110 mM/L for men and >90 mM/L for women; 
� P<0.05; 
�P<0.01.
Physiological factors
Men (n=364)
Case*/total no. (%) Adjusted OR (95% CI)
Women (n=507)
Case*/total no. (%) Adjusted OR (95% CI)
Serum folate
Normal (≥11.3 nM/L) 12/193 ( 6.2) 1.0 20/425 (4.7) 1.0
Borderline (6.8-11.2 nM/L) 19/120 (15.8) 2.86 (1.26-6.48)
� 16/68 (23.5) 5.12 (2.20-11.9)
�
Deficient (<6.8 nM/L) 18/51 (35.3) 10.8 (4.35-26.9)
� 4/14 (28.6) 4.55 (1.01-20.6)
�
P for trend <0.001 <0.001
Serum vitamin B12
Normal (≥185 pM/L) 34/293 (11.6) 1.0 26/431 (6.0) 1.0
Borderline (148-184.9 pM/L) 4/30 (13.3) 1.26 (0.37-4.25) 1/33 (3.0) 0.62 (0.08-5.05)
Deficient (<148 pM/L) 11/41 (26.8) 2.67 (1.09-6.50)
� 13/43 (30.2) 6.00 (2.48-14.6)
�
P for trend 0.046 0.001
Serum creatinine
Normal 41/352 (13.0) 1.0 33/497 (6.6) 1.0
Elevated
� 8/12 (66.7) 19.7 (4.79-81.2)
� 7/10 (70.0) 19.6 (3.96-96.7)
�
Table 3. Risk of hyperhomocysteinemia in relation to serum levels of folate, vitamin B12, and creatinine by sex
OR, odds ratio adjusted for sex, age, and serum creatinine levels; *P<
0.01; 
� interaction between folate and vitamin B12 was statistically sig-
nificant (P<0.001).
Serum folate
Adjusted OR (95% CI)
Serum vitamin B12
≥148 pM/L <148 pM/L
≥6.8 nM/L 1.0 4.09 (2.13-7.85)*
<6.8 nM/L 4.04 (1.94-8.45)* 31.7 (7.20-139.8)*,�
Table 4. Interaction effects of serum folate and vitamin B6 levels
on hyperhomocysteinemiacentration of tHcy in our subjects were similar to that of 195
healthy Koreans selected in a hospital setting (10), but lower
than that of 204 healthy Korean visitors to a medical center
(11). These differences in tHcy concentrations can be attribut-
ed to variations in the blood concentrations of folate and vita-
min B12 in the population of each country. Folate deficien-
cy was not common in our study sample; only 14% of men
and 2.8% of women were classified as folate deficient (<6.8
nM/L), compared to 37% in the north Chinese population
(12) and 31% of urban women and 40% of rural women in
Costa Rica (24) using the same criteria. This lower prevalence
of serum folate deficiency seems to be due to higher consump-
tion of vegetables, including kimchi, in Koreans. Kimchi is
one of the main sources of folate in Korean foods (25). Addi-
tionally, the serum folate deficiency rate in our rural popula-
tion was lower than that of urban Koreans (17.7% in men
and 7.7% in women), who were also found to have a higher
mean tHcy concentration than that of our subjects (11). Based
on the 2005 Korea National Health and Nutrition Survey
(KNHANES), this finding can be explained by the greater
consumption of vegetables and kimchi in the rural population
compared to the urban population (25). In our study, serum
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No. of risk factors*
0 1 2-4
*Folate deficiency (<6.8 nM/L), vitamin B12 deficiency (<148 pM/L), elevated creatinine (>110 mM/L for men and >90 mM/L for women), and family his-
tory of stroke; 
� cut-off points of hyperhomocysteinemia were >15.31 mM/L for men and >12.69 mM/L for women; OR, odds ratio adjusted for age within
two age groups (< 65 yr and ≥65 yr); 
� P<0.05; 
�P<0.01.
Men
<65 yr Case
� /total no. (%) 3/92 (3.3) 16/117 (13.7) 10/44 (22.7)
OR (95% CI) 1.0 4.93 (1.39-17.6)
� 9.27 (2.39-36.0)
�
≥65 yr  Case
� /total no. (%) 1/40 (2.5) 8/47 (17.0) 11/24 (45.8)
OR (95% CI) 1.0 10.5 (1.15-95.5)
� 33.5 (3.71-302.0)
�
Women 
<65 yr  Case
� /total no. (%) 3/222 (1.4) 5/117 (4.3) 6/21 (28.6)
OR (95% CI) 1.0 3.18 (0.74-13.6) 27.0 (6.03-120.6)
�
≥65 yr  Case
� /total no. (%) 3/70 (4.3) 13/62 (21.0) 10/15 (66.7)
OR (95% CI) 1.0 6.30 (1.69-23.5)
� 39.2 (7.95-193.5)
�
Table 6. Risk of hyperhomocysteinemia in relation to the number of the four selected risk factors by sex and age
Adjusted OR (95% CI)
Men (n=364)
Parameters
Age
Parameters
Women (n=507)
Adjusted OR (95% CI)
Men (n=364) Women (n=507)
Family history and disease states of subject
Family history of stroke
No 1.0 1.0
Yes 1.76 (0.74-4.21) 3.07 (1.28-7.36)
�
Diabetes mellitus 
No 1.0 1.0
Yes 1.48 (0.51-4.29) 1.33 (0.44-4.02)
Body Mass Index
Under-Normal range  1.0 1.0
(<23 kg/m
2)
Overweight (23-24.9 kg/m
2) 0.68 (0.28-1.64) 0.38 (0.12-1.16)
Obese (≥25 kg/m
2) 0.61 (0.28-1.31) 0.48 (0.21-1.09)
Hormonal factors (only women)
Menopause
No 1.0
Yes 1.26 (0.26-6.19)
Oral contraceptive use
No 1.0
Yes 0.99 (0.36-2.75)
Lifestyle factors
Smoking
None 1.0 1.0
Ex-smoker 0.82 (0.33-2.02)* 1.57 (0.29-8.41)*
Current smoker 0.71 (0.32-1.57)* 1.04 (0.34-3.18)*
Alcohol drinking
None 1.0 1.0
Ex-drinker 0.81 (0.26-2.57)* 0.85 (0.18-4.12)*
Current drinker 1.04 (0.44-2.45)* 1.11 (0.51-2.40)*
Coffee consumption
None 1.0 1.0
≤1 cup/day 1.57 (0.31-8.11) 1.19 (0.33-4.28)
≥2 cups/day 1.24 (0.22-7.04) 0.28 (0.05-1.76)
Sedentary time
�
≤5.5 hr/day 1.0 1.0
5.6-9.0 hr/day 1.31 (0.55-3.13) 1.39 (0.56-3.44)
>9.0 hr/day 1.81 (0.83-3.97) 1.31 (0.52-3.32)
Table 5. Risk of hyperhomocysteinemia in relation to family history, disease state, and hormonal and lifestyle factors by sex
OR, odds ratio adjusted for age, serum concentrations of folate, vitamin B12, and creatinine; *adjusted for only age and serum creatinine; 
� sum of the
time spent sedentary while eating at a table, watching TV, driving the car and taking the bus, sitting indoors (reading a book, knitting, or talking, etc.),
and working in a seated position, which was classified into tertile groups; 
� P<0.05.deficiency of folate or vitamin B12 was significantly associ-
ated with the risk of hyperhomocysteinemia. Furthermore,
the risk of hyperhomocysteinemia was largely increased in
subjects with deficient concentrations of folate and vitamin
B12 compared with persons who have adequate concentra-
tions of both vitamins (OR, 31.7; 95% CI, 7.20-139.8). The
interaction between folate and vitamin B12 concentrations
was significant. These results can be explained by homocys-
teine metabolism, in which the remethylation process of homo-
cysteine is dependent on a vitamin B12-denpendent enzyme
and folate in the form of 5-methyltetrahydrofolate (8).
In our study, serum tHcy concentrations increased signifi-
cantly with age in both men and women, whereas serum con-
centrations of folate and vitamin B12 did not decrease with
age. This indicates that the serum tHcy levels in the older
age group may be influenced by other factors related to homo-
cysteine metabolism rather than vitamin levels, such as the
decreased activity of several related enzymes (26), physiolog-
ic decline in renal function (27), and hormonal changes (28)
in the elderly. In our study, the risk of hyperhomocysteine-
mia was more dramatically increased in women over 65 yr
of age than in men of the same age group (OR, 6.03; 95%
CI, 2.02-19.7 in women over 65 yr; OR, 2.74; 95% CI, 1.04-
7.22 in men over 65 yr), but the age effect in women disap-
peared after controlling for menopause (data not shown). Mech-
anisms of increased tHcy levels after menopause are largely
unknown. Previous work suggests that higher postmeno-
pausal tHcy levels may be related to the lower methionine
transamination or estrogen deficiency (28). 
With regard to the factor of sex, the mean concentration
of tHcy in men was significantly higher than the concentra-
tions measured in women. This can be partly explained by
the significantly lower serum folate and vitamin B12 concen-
trations in men compared to women. However, the mean
difference in tHcy concentrations between men and women
still remained significant after controlling for serum folate
and vitamin B12 levels (data not shown). This residual sex
difference may be explained by tHcy formation in connec-
tion with the creatine/creatinine synthesis that is proportion-
al to muscle mass (8). It remains to be established whether
this difference is caused by the smoking, alcohol consump-
tion, and dietary habits of men. However, our study could
not find any associations between these habits and hyperho-
mocysteinemia in either sex.
In our study, none of the behavioral factors (smoking, alco-
hol consumption, coffee consumption, and physical inactiv-
ity) were associated with the risk of hyperhomocysteinemia.
Relationships between cigarette smoking and plasma homo-
cysteine concentrations are controversial (12, 21, 23, 29). In
our study, the mean serum folate concentrations of current
smokers were significantly lower than those of non-smokers
and ex-smokers. Furthermore, subjects with lower folate con-
centrations showed considerably higher mean tHcy concen-
trations. Considering this, we expected that current smokers
would have an increased risk of hyperhomocysteinemia. Con-
trary to our expectations, however, smoking status was not
associated with the risk of hyperhomocysteinemia. Instead,
the prevalence of hyperhomocysteinemia was lower in male
smokers. This may be explained by the specific characteris-
tics of smokers, such as age. The mean age (52.7±13.4 yr)
of male smokers was significantly lower than the mean age
(59.2±12.2 yr) of male non- and ex-smokers. However, the
association between smoking and hyperhomocysteinemia
before and after controlling for age was similar. There is a
possibility that a residual confounding effect of other factors
related to age could still be present. In addition, this unex-
pected result related to smoking may be due to reverse cau-
sation in that subjects with diabetes mellitus or obesity, fac-
tors considered to increase risk of hyperhomocysteinemia, may
have changed their behavior to improve their health. Although
our result was not significant, cigarette smoking may be indi-
rectly associated with tHcy concentrations via folate; a Chi-
nese study showed that the positive effect of smoking on tHcy
concentrations disappeared after adjusting for plasma folate
concentrations (23). Likewise, in other studies (10, 12, 21, 23),
we have not found any association between alcohol consump-
tion and tHcy concentrations. Besides smoking and alcohol
consumption, little information has been collected on coffee
consumption and physical inactivity as determinants of homo-
cysteine concentrations in the general Asian population (10,
23). Although coffee consumption (30) and physical inactivity
(29) have been shown to increase the risk of hyperhomocys-
teinemia in some Europeans and Americans, a Chinese study
(23) did not detect any association between behavioral factors
(daily coffee consumption, weekly exercise, cigarette smok-
ing, and alcohol consumption) and plasma tHcy concentra-
tions after adjusting for plasma folate concentrations. In addi-
tion, another Korean study also reported that behavioral fac-
tors, such as cigarette smoking, alcohol consumption, and cof-
fee consumption, did not influence plasma tHcy levels (10).
Although serum concentrations of folate and vitamin B12
appear to be strong determinants of hyperhomocysteinemia,
the risk of hyperhomocysteinemia cannot be explained by a
single factor; Homocysteine increased with age, regardless
of the lack of associations between age and serum folate and
vitamin B12 concentrations. Also, differences in tHcy con-
centrations between the sexes remained after controlling for
serum folate and vitamin B12. In line with this, we hypoth-
esized that the risk of hyperhomocysteinemia may be increas-
ed more by several combined factors than by any single fac-
tor. Considering this explanation, we estimated the risk of
hyperhomocysteinemia according to the number of risk fac-
tors (deficiencies in serum folate and vitamin B12, elevated
serum creatinine, and family history of stroke). We found
that the more risk factors a participant had, the higher the
risk for hyperhomocysteinemia. This finding was especially
pronounced in elderly men and women.
One of the limitations of this study is that we cannot clar-
514 H.J. Kim, M.K. Kim, J.U. Kim, et al.ify the causality of folate and vitamin B12 in hyperhomocys-
teinemia due to the cross-sectional design of the study. Also,
the representativeness of our study population as well as sam-
ple size is lack. Regardless of these limitations, this study is
the first study to explore the determining factors for serum
tHcy concentrations in a community-based study with Kore-
an sample. In the future, we will follow up this cohort to con-
firm the associations between serum tHcy concentrations and
the onset or death from CHD.
In conclusion, increased age, male sex, family history of
stroke, deficiencies of serum folate and vitamin B12, and ele-
vated serum creatinine are important determinants of serum
tHcy concentrations with interaction effects between these
factors in a community-based Korean population.
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